These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 10713684)
21. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Vail ME; Pierce RH; Fausto N Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255 [TBL] [Abstract][Full Text] [Related]
22. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
23. Bax accelerates tumorigenesis in p53-deficient mice. Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation. Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327 [TBL] [Abstract][Full Text] [Related]
25. Loss of Stat5a delays mammary cancer progression in a mouse model. Ren S; Cai HR; Li M; Furth PA Oncogene; 2002 Jun; 21(27):4335-9. PubMed ID: 12082622 [TBL] [Abstract][Full Text] [Related]
26. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T; Varmus HE; Donehower LA Cell Growth Differ; 1997 Aug; 8(8):829-38. PubMed ID: 9269892 [TBL] [Abstract][Full Text] [Related]
27. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
28. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Li M; Hu J; Heermeier K; Hennighausen L; Furth PA Cell Growth Differ; 1996 Jan; 7(1):13-20. PubMed ID: 8788029 [TBL] [Abstract][Full Text] [Related]
29. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389 [TBL] [Abstract][Full Text] [Related]
30. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643 [TBL] [Abstract][Full Text] [Related]
31. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941 [TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779 [TBL] [Abstract][Full Text] [Related]
34. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Lane TF; Leder P Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971 [TBL] [Abstract][Full Text] [Related]
35. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus. Zheng X; Hendry WJ Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Jäger R; Herzer U; Schenkel J; Weiher H Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445 [TBL] [Abstract][Full Text] [Related]
39. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
40. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Witty JP; Lempka T; Coffey RJ; Matrisian LM Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]